David McWilliams Biography and Net Worth

Mr. McWilliams has over 40 years of experience in building biopharmaceutical and healthcare companies.  He currently serves as the Chairman of the board of directors of BioHouston, Inc., an advocate of Houston’s life sciences industry.  Mr. McWilliams has served as a consultant and an advisor at various levels in multiple private start-up biotech companies to help develop pre-clinical and clinical assets in cancer and other therapeutic areas.  He has also served as the Chief Executive Officer and a member of the board of directors of Opexa Therapeutics, Inc., a multiple sclerosis cell therapy company; as the Chief Executive Officer, President and a member of the board of directors of Bacterial Barcodes, Inc., a bacteria and fungi diagnostic company; as the Chief Executive Officer and a member of the board of directors of Signase, Inc., a cancer therapeutics company; as Chief Executive Officer, President, and a member of the board of directors of both Encysive Pharmaceuticals, Inc. and Repros Therapeutics Inc.; and as Chief Executive Officer and President of Kallestad Diagnostics (Erbamont).  Mr. McWilliams has served in various other capacities, including President of Harleco Diagnostics Division (EM Industries), General Manager and Program Manager of Abbott Laboratories, and Management Consultant at McKinsey & Company.  Mr. McWilliams was previously the Chief Executive Officer of Greenwich LifeSciences.  He received a BA in Chemistry from Washington and Jefferson College, and an MBA in Finance from the University of Chicago.